Haematologica 2024 Oct 24
Prevention and treatment of transformation of myeloproliferative neoplasms to acute myeloid leukemia.
Related Questions
As the cost of NGS decreases over time, is there still a need for more focused/targeted panels such as JAK2, CALR, and MPL? Are other genes important ...
New comment by at Johns Hopkins University ( November 21, 2025)
Many thanks for your interest, Dr. Robbins.
Cheers,
JLS